These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 5587566)
1. The diagnostic and therapeutic use of diphenylhydantoin in the subictal state and non-epileptic dysphoria. Jonas AD Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:21-9. PubMed ID: 5587566 [No Abstract] [Full Text] [Related]
3. The usefulness of diphenylhydantoin in treatment of non-epileptic emotional disorders. Turner WJ Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:8-20. PubMed ID: 5587569 [No Abstract] [Full Text] [Related]
4. Diphenylhydantoin and phenobarbital in the relief of psychoneurotic symptoms. A controlled comparison. Uhlenhuth EH; Stephens JH; Dim BH; Covi L Psychopharmacologia; 1972; 27(1):67-84. PubMed ID: 4562952 [No Abstract] [Full Text] [Related]
5. [Chronic depression]. Weitbrecht HI Wien Z Nervenheilkd Grenzgeb; 1967; 24(4):265-81. PubMed ID: 4227555 [No Abstract] [Full Text] [Related]
6. [Additional observations on the psychopathology of "neurotic schizophrenias". Reflective experience dynamics as defense and protective mechanisms against the schizophrenic personality dissociation]. Simkó A Nervenarzt; 1968 Jun; 39(6):251-5. PubMed ID: 5712429 [No Abstract] [Full Text] [Related]
7. [CLINICAL EXPERIENCES WITH VALIUM ROCHE, A NEW BENZODIAZEPINE DERIVATIVE]. HARDER A Schweiz Med Wochenschr; 1964 Mar; 94():424-8. PubMed ID: 14189257 [No Abstract] [Full Text] [Related]
8. [Features of the clinical effect of benzodiazepine derivatives (according to the findings of comparative studies). Review of the literature]. Prokudin VN Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):285-95. PubMed ID: 4582691 [No Abstract] [Full Text] [Related]
9. Reliability of a procedure for measuring and classifying "present psychiatric state". Wing JK; Birley JL; Cooper JE; Graham P; Isaacs AD Br J Psychiatry; 1967 May; 113(498):499-515. PubMed ID: 6033492 [No Abstract] [Full Text] [Related]
11. [Frequency of suicidal acts in psychoses]. Lipanov RG Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(8):1204-8. PubMed ID: 7211047 [TBL] [Abstract][Full Text] [Related]
12. Classification and treatment of depression. Blinder MG Int Psychiatry Clin; 1969; 6(2):3-26. PubMed ID: 5810565 [No Abstract] [Full Text] [Related]
14. [Characteristics of psychiatric expert testimony in suicide]. Kalashnik IaM Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(4):625-8. PubMed ID: 6000932 [No Abstract] [Full Text] [Related]
15. [On the use of Librium and Valium in general medicine, in adults]. Chassagnon C J Med Lyon; 1967 Jun; 48(123):1059-80. PubMed ID: 5618071 [No Abstract] [Full Text] [Related]
17. [Diagnostic agreement between clinicians and the program DIAL. A study in computer assisted diagnosis (author's transl)]. Schmid W; Castell R; Mombour W; Mittelsten Scheid D; von Zerssen D Arch Psychiatr Nervenkr (1970); 1974 Apr; 218(4):339-51. PubMed ID: 4600792 [No Abstract] [Full Text] [Related]
18. The psychoactive properties of diphenylhydantoin: experiences with prisoners and juvenile delinquents. Resnich O Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:30-6. PubMed ID: 4873471 [No Abstract] [Full Text] [Related]
19. Reduced CSF IgG in patients treated with phenytoin (diphenylhydantoin). Fossan GO Eur Neurol; 1976; 14(6):426-32. PubMed ID: 991879 [TBL] [Abstract][Full Text] [Related]
20. [The significance of structural dynamics for a theory of neurosis and personality disorders]. Frommer J Nervenarzt; 2003 Jan; 74(1):23-9. PubMed ID: 12596024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]